Treatment of Retinoblastoma 1–Intact Hepatocellular Carcinoma With Cyclin‐Dependent Kinase 4/6 Inhibitor Combination Therapy-Reference-Cited by-同舟云学术

Treatment of Retinoblastoma 1–Intact Hepatocellular Carcinoma With Cyclin‐Dependent Kinase 4/6 Inhibitor Combination Therapy

Published:2021-08-25 Issue:4 Volume:74 Page:1971-1993
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sheng Jindan¹,Kohno Susumu¹,Okada Nobuhiro²,Okahashi Nobuyuki³,Teranishi Kana¹,Matsuda Fumio³,Shimizu Hiroshi³,Linn Paing¹,Nagatani Naoko¹,Yamamura Minako⁴,Harada Kenichi⁴,Horike Shin‐ichi⁵,Inoue Hiroshi⁶,Yano Seiji¹,Kumar Sharad⁷,Kitajima Shunsuke¹⁸⁹,Ajioka Itsuki¹⁰¹¹,Takahashi Chiaki¹^ORCID

Affiliation:

1. Cancer Research Institute Kanazawa University Kanazawa Japan

2. Graduate School of Interdisciplinary Science and Engineering in Health Systems Okayama University Okayama Japan

3. Graduate School of Information Science and Technology Osaka University Suita Japan

4. Graduate School of Medical Sciences Kanazawa University Kanazawa Japan

5. Advanced Science Research Center Kanazawa University Kanazawa Japan

6. Institute for Frontier Science Initiative Kanazawa University Kanazawa Japan

7. Centre for Cancer Biology University of South Australia Adelaide SA Australia

8. Cancer Institute Japanese Foundation for Cancer Research Tokyo Japan

9. Dana‐Farber Cancer Institute Harvard Medical School Boston MA

10. Center for Brain Integration Research Tokyo Medical Dental University Tokyo Japan

11. Kanagawa Institute of Industrial Science and Technology Kanagawa Japan

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31872

Reference33 articles.

1. CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

2. Fulvestrant in combination with CDK4/6 inhibitors for HER2‐ metastatic breast cancers: current perspectives;Iorfida M;Breast Cancer,2020

3. Hepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein

4. Hepatitis B Virus Pre-S2 Mutant Surface Antigen Induces Degradation of Cyclin-Dependent Kinase Inhibitor p27Kip1 through c-Jun Activation Domain-Binding Protein 1

5. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK4/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells;Journal of Advanced Research;2024-08

2. DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity;British Journal of Cancer;2024-06-01

3. Indole-3-Carboxylic Acid Enhanced Anti-cancer Potency of Doxorubicin via Induction of Cellular Senescence in Colorectal Cells;Acta Poloniae Pharmaceutica - Drug Research;2024-04-09

4. RB1 loss induces quiescent state through downregulation of RAS signaling in mammary epithelial cells;Cancer Science;2024-03-11

5. SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer;Cell Reports;2024-03